3 infants dead after bacterial infection at Pa. hospital

The hospital said all of the babies had been born prematurely


A Pennsylvania hospital is trying to determine the source of a waterborne germ that appears to have infected at least eight infants in the neonatal intensive care unit, three of whom have died, according to an article on the Today website.

Geisinger Medical Center in Danville is sending very premature newborns and some expectant mothers to other facilities while officials investigate.

Four babies have recovered from an infection caused by the Pseudomonas bacterium, and one is still being treated with antibiotics.

Cultures of the water supply and surfaces inside the neonatal intensive care unit, where all the infections occurred, tested negative for Pseudomonas.

Read the article.

 



October 10, 2019


Topic Area: Infection Control


Recent Posts

Women in Construction Sees Growth on Florida Jobsite

More than 60 women are part of the workforce building a new Orlando Health Hospital.


Managing Soft Surfaces, Clean or Soiled

Soft surfaces present a cross-contamination risk, even if they’re arriving from the laundry. Here are some best practices to handle both soiled and clean linens.


Ascension St. Vincent's Expands with New Freestanding Emergency Room

The ER facility will be operated by Ascension St. Vincent’s Southside.


Balancing Act: Designing for Safety and Flexibility

By understanding NFPA 99 requirements, facilities can be better designed to meet current needs and anticipate future challenges.


Methodist Healthcare Breaks Ground on Methodist ER Medina Valley

Construction began in March 2026 and is projected for completion by March 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.